Stress Helps Ovarian Cancer Cells Escape
Conquest - Summer 2010
Chronic stress triggers a chain of molecular events that protects breakaway ovarian cancer cells from destruction.
In preclinical research, scientists found that heightened levels of the fight-or-flight stress hormones epinephrine and norepinephrine permit more malignant cells to safely leave the primary tumor, a necessary step in metastasis and cancer progression.
They also found that ovarian cancer patients face earlier mortality when a crucial protein activated by the hormones is present at high levels in their tumors and that patients with depression have higher levels of this activated protein.
Two promising approaches — directly silencing a crucial protein or using beta blockers to preempt its activation — worked in cell culture and mouse models, making them candidates for human use.
“Restoring cancer cells’ vulnerability to anoikis (a form of programmed cell death) would open a new avenue for suppressing tumor growth and metastasis,” says Anil Sood, M.D., professor in MD Anderson’s departments of Gynecologic Oncology and Cancer Biology and first author.
Reported in the May 3 issue of the Journal of Clinical Investigation.
Conquest - Summer 2010
- Survivorship: the Next Step
- Radiological Physics Center Ensures Strength, Applicability of Clinical Trial Results
- It's All Happening in the Children's Cancer Hospital
- Nurturing Future Cancer Prevention Leaders
- Volunteer Pilots Help Connect Patients With Treatment
- Cancer Survivors' Stories: Reasons to Give
- Baseline PET Scans Becoming More Routine
- Moving Forward: Lisa Richardson
- Signs of Hope: 'Beads of Courage' Helps Children Cope With Cancer Treatment
- Chemo Combo Shows Promise for Endometrial Cancer Patients
- The Battle Against Lung Cancer Is On
- Chemoprevention for Colon Cancer
- Busulfan Improves Outcomes for Stem Cell Transplant Patients
- Bladder Cancer Risk Higher for Those Who Eat Well-Done Meat
- Stress Helps Ovarian Cancer Cells Escape
- Blood Count Test Helps Predict Leukemia Treatment Outcomes
- Genes Help Identify Some Glioblastomas
- Tool Measures Severity of Transplant-Related Symptoms
- New Guidance for Decisions on Preventive Breast Surgery
- Also in the News